Matches in Nanopublications for { ?s ?p ?o <http://bio2rdf.org/drugbank_resource:DB00582_DB01319_nanopub.RAZyLb9CRjTeyGDs6WQNXmkoOg5Ax3Xmrui8E87t7DXvY#assertion>. }
Showing items 1 to 6 of
6
with 100 items per page.
- drugbank_resource:DB00582_DB01319 type drugbank_vocabulary:Drug-Drug-Interaction assertion.
- drugbank_resource:DB00582_DB01319 label "DDI between Voriconazole and Fosamprenavir - Voriconazole may increase the serum concentration of fosamprenavir by decreasing its metabolism. Fosamprenavir may increase the serum concentration of voriconazole. Monitor for changes in the therapeutic and adverse effects of both agents if concomitant therapy is initiated, discontinued or if doses are changed. [drugbank_resource:DB00582_DB01319]" assertion.
- drugbank_resource:DB00582_DB01319 identifier "drugbank_resource:DB00582_DB01319" assertion.
- drugbank_resource:DB00582_DB01319 title "DDI between Voriconazole and Fosamprenavir - Voriconazole may increase the serum concentration of fosamprenavir by decreasing its metabolism. Fosamprenavir may increase the serum concentration of voriconazole. Monitor for changes in the therapeutic and adverse effects of both agents if concomitant therapy is initiated, discontinued or if doses are changed." assertion.
- drugbank:DB00582 drugbank_vocabulary:ddi-interactor-in drugbank_resource:DB00582_DB01319 assertion.
- drugbank:DB01319 drugbank_vocabulary:ddi-interactor-in drugbank_resource:DB00582_DB01319 assertion.